AI-powered precision neuropsychiatry

Our predictive biomarker platform delivers personalized assessments of brain health to accelerate therapeutics for patients with psychiatric & neurological disorders.

We fuse generative AI with computational neuroscience

Our platform's algorithms are rigorously trained to model the brain's inherent complexity. We can classify major psychiatric disorders (MDD, ADHD, PTSD, OCD, SCZ) and predict treatment response up to 50% better than current “state of the art.”

Our solutions

Accelerate clinical trials and therapy development

Using cross-validated AI/ML models, our biomarker platform de-risks both preclinical and clinical R&D to bring innovative therapies to patients sooner. We generate prospective insights on treatment efficacy, placebo response, dose selection, & much more.

Help providers deliver effective treatments

Our clinic integrations eliminate the trial-and-error approach to mental health and neurological care. Through the collection and analysis of EEG/ECG data and VR assessment, we help care providers better understand patient conditions, measure progress, & improve outcomes.

Empower everyone to own & track their brain health

There’s nothing more complex or critical to overall performance than optimizing the brain’s functionality. Our technology generates reports and insights for biohackers, early adopters of psychedelic medicine, or anyone that values objective measurements into their health.

Our partners

Award-winning predictive capabilities

In an international competition to validate clinically-actionable biomarkers, our approach ranks #1 among dozens of data science teams.

Meet the executive and computational team

We bring together the sharpest minds in computational neuroscience, generative artificial intelligence, integrative neurotechnology, psychedelic medicine, & clinical care innovation, including experimental psychiatrists and open science pioneers with 100's of high impact papers & patents.

Shobi Ahmed, MD PhD

Chief Executive Officer Founder

Shobi Ahmed, MD PhD

Chief Executive Officer Founder

Shobi Ahmed, MD PhD

Chief Executive Officer Founder

Kristel Carrington, MD

Chief Medical Officer, Co-Founder

Kristel Carrington, MD

Chief Medical Officer Co-Founder

Kristel Carrington, MD

Chief Medical Officer, Co-Founder

Adam Teed, PhD

Chief Operating Officer, Co-Founder

Adam Teed, PhD

Chief Operating Officer Co-Founder

Adam Teed, PhD

Chief Operating Officer, Co-Founder

Tyler Moore, PhD

Chief Development Advisor

Tyler Moore, PhD

Chief Development Advisor

Alan Tucholka, PhD

Chief Technology Officer

Alan Tucholka, PhD

Chief Technology Officer

Elias Mouchlianitis, PhD

Chief Scientific Officer

Elias Mouchlianitis, PhD

Chief Scientific Officer

Russel Hanson, PhD

Chief Innovation Officer

Russel Hanson, PhD

Chief Innovation Officer

Mollie Fleury

Chief of Staff

Mollie Fleury

Chief of Staff

Franz Hell, PhD

Chief AI Officer

Franz Hell, PhD

Chief AI Officer

Karim El Kanbi, PhD

Head of AI/ML

Karim El Kanbi, PhD

Head of AI/ML

Our advisory board

We’re fortunate to benefit from the collective wisdom of the most (in our opinion) innovative and reputable figures in precision neuropsychiatry.

Diego Pizzagalli, PhD

Professor, Psychiatry Harvard Medical School

Diego Pizzagalli, PhD

Professor, Psychiatry Harvard Medical School

Laura Bevilacqua, MD PhD

Psychiatrist & Professor, Mt. Sinai School of Medicine

Laura Bevilacqua, MD PhD

Psychiatrist & Professor, Mt. Sinai School of Medicine

Konrad Kording, PhD

Professor, PIK, University of Pennsylvania

Konrad Kording, PhD

Professor, PIK, University of Pennsylvania

John Allen, PhD

Distinguished Professor, Psychology, University of Arizona

John Allen, PhD

Distinguished Professor, Psychology, University of Arizona

Stephen Morse, JD PhD

Professor of Law in Psychiatry, Penn

Stephen Morse, JD PhD

Professor of Law in Psychiatry, Penn

Martijn Arns, PhD

Professor, Neuroscience, Maastricht University, Director, Brainclinics

Martijn Arns, PhD

Professor, Neuroscience, Maastricht University, Director, Brainclinics

Adam Safron, PhD

Founding Chief Scientific Officer, Postdoc, JHU

Adam Safron, PhD

Founding Chief Scientific Officer, Postdoc, JHU

Rex Jung, PhD

Professor of Neurosurgery, University of New Mexico

Rex Jung, PhD

Professor of Neurosurgery, University of New Mexico

Our publications

Together, we're transforming psychiatric and neurological medicine

Find out how we can partner to make a tangible, data-driven difference in the lives of the individuals and communities we serve.